Summary
Johnson & Johnson (JNJ) filed an 8-K on July 17, 2018, to report its second-quarter financial results for the period ended July 1, 2018. The filing includes a press release detailing sales and earnings, as well as supplementary sales data and condensed consolidated statements of earnings. Investors should review this report for insights into the company's operational performance and financial condition during the quarter.
Key Highlights
- 1Johnson & Johnson announced its second-quarter financial results for the period ended July 1, 2018.
- 2The 8-K filing contains a press release detailing the company's sales and earnings for the quarter.
- 3Supplementary sales data and unaudited condensed consolidated statements of earnings are also included as exhibits.
- 4Investors can access detailed financial performance information through the provided press release and financial statements.
- 5This report provides an update on JNJ's operational performance and financial condition for the specified quarter.
Frequently Asked Questions
The main purpose of this 8-K filing is to publicly disclose Johnson & Johnson's second-quarter financial results, including sales and earnings, for the period ended July 1, 2018, along with supporting financial data.
The detailed financial results are primarily available in the press release (Exhibit 99.15) and the unaudited comparative supplementary sales data and condensed consolidated statement of earnings (Exhibit 99.20) attached to this 8-K filing.
The exhibits provide information on the company's sales and earnings for the second quarter of 2018, comparative supplementary sales data, and condensed consolidated statements of earnings for the same period.
The financial results for the second quarter ended July 1, 2018, were announced on July 17, 2018, with the 8-K filing made on the same day.